cough
stomach or intestinal problems, such as ulcerative colitis or Crohn’s disease
Tell your doctor right away if you have any serious side effects, including: unusual weight gain, menstrual period changes, bone/ joint pain, easy bruising/bleeding, mental/mood changes (such as Allergic reactions
g
Myasthenia
Osteoarthritis
Examples of methylprednisolone’s commonly reported side effects include: nausea and vomiting
multiple sclerosis (MS) colitis
Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered
Steroids can affect growth
low potassium --leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp
It is primarily used to reduce inflammation and suppress the immune system in conditions such as arthritis, asthma, allergies, and certain skin conditions
However, methylprednisolone and prednisone differ in their available forms and side effects Methylprednisolone side effects
4 mg/kg per day (maximum, 32 mg/d) after an interim analysis demonstrated a high rate of adverse events in the intervention group
It is most often used to decrease inflammation and to resolve respiratory symptoms resulting from
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy
It is often used to replace this chemical when your body does not make enough of it
Hepatic effects: High doses of methylprednisolone IV (usually doses of 1 g/day in adults) may induce a toxic form of acute hepatitis (rare); serious hepatic injury may occur, resulting in acute liver failure and death
Oral and intramuscular methylprednisolone are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders
This product is available in the following dosage forms: Tablet
It works on the immune system to help relieve swelling, redness, itching, and allergic reactions
They found no evidence that methylprednisolone increased the risk of GI bleeding, wound complication, pulmonary
A prespecified subgroup analysis did not show evidence of significant differences in the effects of methylprednisolone on the composite kidney failure outcome in subgroups defined by baseline proteinuria (<3
On a limited basis, MPA has also been injected intrathecally in patients suffering from postherp